Dr. Reiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
StrongHolt Therapeutics, LLC
Park City, UT 84098
Summary
- Cardiothoracic Surgeon focused on the Life Science discovery-to-commercialization pathway. COO of StrongHolt Therapeutics, a biotech company chasing down a gene therapy cure for Duchenne muscular dystrophy.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Interventional Cardiology & Hybrid Cardiac Surgery, 2010 - 2011
- University of Utah HealthFellowship, Thoracic Surgery, 2001 - 2003
- University of Utah HealthResidency, Surgery, 1999 - 2001
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Surgery, 1993 - 1999
- Drexel University College of Medicine/Hahnemann UniversityFellowship, Center For Gene Therapy, 1995 - 1998
- Drexel University College of MedicineClass of 1993
- La Salle UniversityBA, General University Honors, 1987
Certifications & Licensure
- PA State Medical License Current
- UT State Medical License 2000 - 2026
- CO State Medical License 2015 - 2025
- WI State Medical License 2011 - 2019
- NY State Medical License 2010 - 2012
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- NYP-Columbia University Medical CenterInterventional Cardiology
Awards, Honors, & Recognition
- Samson Resident Prize Essay Western Thoracic Surgery Association, 2005
- Distinguished Performance Award in Neoplastic Diseases Hahnemann University School of Medicine, 1993
- Alpha Epsilon Delta Premedical Honors Society La Salle University, 1986
- Join now to see all
Clinical Trials
- Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery Start of enrollment: 2008 Aug 01
- Stem Cell Therapy as Adjunct to Revascularization Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 48 citationsEfficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve ReplacementBenoit Daneault, Elana Koss, Rebecca T. Hahn, Susheel Kodali, Mathew R. Williams
Circulation. Cardiovascular Interventions. 2013-01-22 - 19 citationsPatient radiation exposure during transcatheter aortic valve replacement procedures.Benoit Daneault, Stephen Balter, Susheel Kodali, Mathew R. Williams, Philippe Généreux
Eurointervention. 2012-10-01 - 119 citationsStroke Associated With Surgical and Transcatheter Treatment of Aortic Stenosis: A Comprehensive ReviewBenoit Daneault, Ajay J. Kirtane, Susheel Kodali, Mathew R. Williams, Philippe Généreux
Journal of the American College of Cardiology. 2011-11-15
Journal Articles
- Efficacy and Safety of Post-Dilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve ReplacementDaneault, B, Koss, E, Hahn, R, Kodali, SK, Williams, MR, Genereux, P, Paradis, J, George, I, Reiss, GR, Moses, JW, Smith, CR, Leon, MB, Circ Cardiovasc Interv, 1/1/2013
- Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures: Executive SummarySvensson, LG, Adams, DH, Bonow, RO, Kouchoukos, NT, Miller, DC, O'Gara, PT, Shahian, DM, Schaff, HV, Akins, CW, Baveria, J, Blackstone, EH, David, TE, Desai, ND, Dewey..., Ann Thorac Surg, 1/1/2013
- Impact of the Severity of Coronary Artery Calcification on Clinical Events in Patients Undergoing Coronary Artery Bypass Grafting (from the Acute Catheterization and U...Ertelt K, Genereux P, Mintz GS, Reiss GR, Kirtane AJ, Madhavan MV, Fahy M, Williams MR, Brener SJ, Mehran R, Stone GW, Am J Cardiol., 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- HypoxiaInducible VEGF Gene Therapy Using the RTP801 PromoterChoi, D, Lee, M, Bull, DA, Reiss, GR, Chang, C, Christensen, L, Kim, SW, Molecular Therapy, 1/1/2004
- Suppression of the alpha-1,3-Galactosyl Epitope by Golgi Expression of a Coffee Bean alpha-1,3-Galactosidase TransgeneLangell, JT, Reiss, GR, Strong, J, Kresh, JY, Blankenhorn, EP, Transplantation, 1/1/1998
- 3-Azido-3-Deoxythymidine Decreases Cell Surface Expression of the alpha-1,3-Galactosyl Carbohydrate on Porcine Endothelial CellsLangell, JT, Reiss, GR, Cramer, DV, Blankenhorn EP, Kresh, JY., Transplantation, 1/1/1998
- Join now to see all
Lectures
- Management of Iliac Vascular Complications in TAVRUniversity of Wisconsin, Madison, WI - 1/20/2013
- New Paradigms in the Management of Valvular Heart DiseaseMadison, Wisconsin - 1/5./2012
- Transcatheter Cardiovascular Therapies (TCT)San Francisco, CA - 1/7./2011
- Join now to see all
Research History
- PhD CandidateCenter for Gene Therapy & Institute for Cellular Technology1995 - 1998
Professional Memberships
- Member
- American Society of Gene & Cell TherapyMember
External Links
- Russ @LinkedInhttp://www.linkedin.com/in/russreiss
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: